10-Q

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)
þ	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2011

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to 

Commission File No. 333-72376

MEDICAL CONNECTIONS HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Florida	65-0920373
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
4800 T Rex Avenue Suite 310 Boca Raton, Florida	33431
33----dddd33
(Address of principal executive office)	(Zip Code)

Registrant’s telephone number, including area code: (561) 353-1110

Former name, former address and former fiscal year, if changed since last report.

Indicate by a check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.       Yes þ     No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  þ  No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	o	Accelerated filer	o
Non-accelerated filer	o	Smaller reporting company	þ
(Do not check if smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)    Yes o     No þ

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer’s classes of Common Stock as of the latest practicable date:

 15,994,333 shares of Common Stock, $.001 par value as of October 31, 2011

INDEX

		PAGE
PART I. – FINANCIAL INFORMATION
Item 1.	Financial Statements
	Condensed Consolidated Balance Sheets at September 30, 2011 (unaudited) and December 31, 2010		3
	Condensed Consolidated Statements of Operations for the Three Months Ended September 30, 2011 and September 30, 2010 (unaudited)		4
	Condensed Consolidated Statements of Operations for the Nine Months Ended September 30, 2011 and September 30, 2010 (unaudited)		5
	Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2011 and September 30, 2010 (unaudited)		6
	Notes to Condensed Consolidated Financial Statements as of September 30, 2011 (unaudited)		7-13
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		14
Item 3.	Quantitative and Qualitative Disclosures about Market Risk		19
Item 4.	Controls and Procedures		19
PART II. – OTHER INFORMATION
Item 1.	Legal Proceedings		20
Item 1A.	Risk Factors		20
Item 2.	Unregistered Sales of Equity Securities		20
Item 3.	Defaults upon Senior Securities		20
Item 4.	(Removed and Reserved)		20
Item 5.	Other Information		20
Item 6.	Exhibits		21

2

MEDICAL CONNECTIONS HOLDINGS, INC., AND SUBSIDIARY

CONDENSED CONSOLIDATED BALANCE SHEETS

SEPTEMBER 30, 2011 (UNAUDITED) AND DECEMBER 31, 2010

	September 30,			December 31,
	2011			2010
ASSETS
Current assets
Cash	$	325,915		$	1,698,030
Accounts receivable, net		791,381			1,352,506
Prepaid expenses		3,995			2,996
Total current assets		1,121,291			3,053,532
Property and equipment		827,228			919,763
Less: accumulated depreciation		280,442			313,772
		546,786			605,991
Other assets
Security deposit		200,000			200,000
Intangible asset, net of amortization of $210,000 and $142,500, respectively		61,481			128,981
		261,481			328,981
Total assets	$	1,929,558		$	3,988,504
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable	$	307,079		$	324,824
Accrued expenses		101,391			174,802
Total current liabilities		408,470			499,626
Stockholders' equity
Preferred stock, Class A, $.001 par value; 100,000 shares
authorized, 5,546 issued and outstanding		5			5
Preferred stock, Class B, $.001 par value; 50,000 shares
authorized, -0- and 50,000 issued and outstanding, respectively		-			50
Preferred stock, Class C, $.001 par value; 215,000 shares
authorized, 215,000 and 120,000 issued and outstanding, respectively		215			120
Common stock, $.001 par value, 20,000,000 shares authorized,
14,129,666 and 11,150,396  issued and outstanding, respectively		14,130			11,150
Additional paid-in capital		45,580,118			44,805,613
Accumulated deficit		(44,073,380	)		(41,328,060	)
Total stockholders' equity		1,521,088			3,488,878
Total liabilities and stockholders' equity	$	1,929,558		$	3,988,504

See the accompanying notes to the condensed consolidated financial statements

3

MEDICAL CONNECTIONS HOLDINGS, INC., AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2011 AND 2010

	(unaudited)			(unaudited)
	2011			2010
Revenue	$	1,362,871		$	2,264,713
Direct costs of revenue		990,624			1,755,751
Advertising and marketing expenses		60,394			30,552
Recruiting - salaries and costs		340,331			420,800
Professional and consulting fees		62,074			73,104
General and administration expenses		741,454			819,505
Total operating expenses		2,194,877			3,099,712
Loss from operations		(832,006	)		(834,999	)
Other expenses, net		110,800			349,636
Loss before income taxes		(942,806	)		(1,184,635	)
Income taxes		-			-
Net loss	$	(942,806	)	$	(1,184,635	)
Net loss per common share - basic and diluted	$	(0.07	)	$	(0.16	)
Weighted average common shares outstanding
- basic and diluted		13,097,401			7,523,182

See the accompanying notes to the condensed consolidated financial statements

4

MEDICAL CONNECTIONS HOLDINGS, INC., AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2011 AND 2010

	(unaudited)			(unaudited)
	2011			2010
Revenue	$	5,173,448		$	5,603,505
Direct costs of revenue		3,810,790			4,214,657
Advertising and marketing expenses		147,241			141,786
Recruiting - salaries and costs		1,052,939			1,276,756
Professional and consulting fees		205,371			412,881
General and administration expenses		2,415,133			2,783,085
Total operating expenses		7,631,474			8,829,165
Loss from operations		(2,458,026	)		(3,225,660	)
Other expenses, net		287,294			2,499,448
Loss before income taxes		(2,745,320	)		(5,725,108	)
Income taxes		-			-
Net loss	$	(2,745,320	)	$	(5,725,108	)
Net loss per common share - basic and diluted	$	(0.23	)	$	(0.86	)
Weighted average common shares outstanding
- basic and diluted		11,914,010			6,666,178

See the accompanying notes to the condensed consolidated financial statements

5

MEDICAL CONNECTIONS HOLDINGS, INC., AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2011 AND 2010

	(unaudited)			(unaudited)
	2011			2010
Cash flow from operating activities
Net loss	$	(2,745,320	)	$	(5,725,109	)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization		155,699			108,894
Common stock issued for compensation		-			275,000
CHANGES IN ASSETS AND LIABILITIES
Accounts receivable		561,125			(554,669	)
Prepaid expenses		(999	)		94,520
Accounts payable and accrued expenses		(91,156	)		439,184
Net cash used in operating activities		(2,120,651	)		(5,362,180	)
Cash flow from investing activities
Acquisition of property and equipment		(28,994	)		(530,361	)
Net cash used in investing activities		(28,994	)		(530,361	)
Cash flow from financing activities
Proceeds from issuance of common stock and warrant exercise		777,530			5,334,648
Net cash provided by financing activities		777,530			5,334,648
Net decrease in cash and cash equivalents		(1,372,115	)		(557,893	)
Cash and cash equivalents at beginning of period		1,698,030			1,017,843
Cash and cash equivalents at end of period	$	325,915		$	459,949
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest	$	-		$	-
Taxes	$	-		$	-

See the accompanying notes to the condensed consolidated financial statements

6

Medical Connections Holding, Inc. and Subsidiary

Notes to Condensed Consolidated Financial Statements

September 30, 2011

NOTE 1 - ORGANIZATION AND BASIS OF PRESENTATION

Medical Connections Holdings, Inc. and its wholly-owned subsidiary (the "Company," "we" or "us") is a healthcare staffing company which provides staffing services for allied professionals and nurses to our clients on a national basis.  We provide recruiting and staffing services for permanent and temporary positions, with an option for the clients and candidates to choose the most beneficial working arrangements.

The Company operates under a holding company structure and has one direct wholly-owned operating subsidiary, Medical Connections, Inc., a Florida corporation ("Medical Connections") which was formed in 2002.

On June 20, 2011, the Company effectuated a 1-for-10 reverse stock split. All share and per share data for all periods presented have been revised to give retroactive effect to the reverse stock split.

In our opinion, the accompanying condensed consolidated balance sheets and related condensed consolidated interim statements of operations and cash flows include the adjustments (consisting of normal and recurring items) necessary for their fair presentation in conformity with United States generally accepted accounting principles ("GAAP") and represent our accounts after the elimination of inter-company transactions. The unaudited information included in this Form 10-Q should be read in conjunction with the consolidated financial statements contained in our 2010 Annual Report on Form 10-K/A which was filed with the Securities and Exchange Commission on July 1, 2011. Interim results are not necessarily indicative of expected results for a full year or for any interim periods in the future.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

PRINCIPLES OF CONSOLIDATION

The consolidated financial statements include the accounts of Medical Connections Holdings, Inc., and its wholly-owned subsidiary. All material inter-company transactions and balances have been eliminated in consolidation.

USE OF ESTIMATES

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

7

ALLOWANCES FOR DOUBTFUL ACCOUNTS / SALES ALLOWANCE

Accounts are written off when management determines that an account is uncollectible. Recoveries of accounts previously written off are recorded when received. Estimated allowances for doubtful accounts ($50,000 as of September 30, 2011 and December 31, 2010) are determined to reduce the Company's receivables to their carrying value, which approximates fair value. Estimated allowances for sales “falloffs” ($60,000 as of September 30, 2011 and December 31, 2010) provide for that portion of permanent placement revenue that may be discounted after a reasonable period of time.  All allowances are estimated based on historical collection experience, specific review of individual customer accounts, and current economic and business conditions. A roll forward of the allowance for doubtful accounts and sales allowances is as follows:

Balance, January 1, 2011	$	110,000
Additions:
Bad debt expense		9,273
Sales allowance		40,654
Deductions:
Write offs		49,927
Balance, September 30, 2011	$	110,000

ADVERTISING

           The Company's policy is to expense the costs of advertising and marketing as they are incurred. Advertising expense for the three months ended September 30, 2011 and 2010 was $60,394 and $30,552, respectively.  For the first nine months ended September 30, 2011 and 2010, advertising expense was $147,241 and $141,786, respectively.

INCOME TAXES

           We account for income taxes in accordance with ASC 740, “Accounting for Income Taxes”, as clarified by ASC 740-10, “Accounting for Uncertainty in Income Taxes”.  Under this method, deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax basis of assets and liabilities given the provisions of enacted tax laws. Deferred income tax provisions and benefits are based on changes to the assets or liabilities from year to year. In providing for deferred taxes, we consider tax regulations of the jurisdictions in which we operate, estimates of future taxable income, and available tax planning strategies. If tax regulations, operating results or the ability to implement tax-planning strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the “more likely than not” criteria of ASC 740.

8

ASC 740-10 requires that we recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the “more-likely-than-not” threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.

           COMMON STOCK ISSUED FOR OTHER THAN CASH

           Services purchased and other transactions settled in the Company's common stock are recorded at the estimated fair value of the stock issued if that value is more readily determinable than the fair value of the consideration received.

EARNINGS (LOSS) PER SHARE OF COMMON STOCK

            Basic loss per share excludes dilution and is computed by dividing the loss attributable to common shareholders by the weighted-average number of common shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that shared in the loss of the Company. Diluted loss per share is computed by dividing the loss available to common stockholders by the weighted average number of common shares outstanding for the period and dilutive potential common shares outstanding unless consideration of such dilutive potential common shares would result in anti-dilution. Common stock equivalents were not considered in the calculation of diluted loss per share as their effect would have been anti-dilutive for the periods ended September 30, 2011 and 2010.  As of September 30, 2011 and 2010, there were common stock equivalents of 606,687 shares excluded from the diluted loss per share calculation.

REVENUE RECOGNITION

           The Company records its transactions under the accrual method of accounting whereby revenue is recognized when the services are rendered and collection is reasonably assured. The Company recognizes revenue from permanent placement services when it sends an invoice to the contracting employer, which is typically when the candidate has   commenced employment. Adjustments to the fee for these services occur if the candidate’s performance is not satisfactory or if the candidate does not commence work requiring the Company to find a replacement candidate. Contract appointments include contracts for what is commonly known as “travel positions,” which are for allied health professionals, nurses or physicians who are willing to take temporary assignments outside their home region. Under this arrangement, we are the employer of record for the healthcare professional. The healthcare facility remits a fee to us that includes all employment overhead, as well as a surcharge for the service. The revenue from this activity is earned from the commission and surcharge for the service which is billed and recognized as services are rendered.

9

FAIR VALUE OF FINANCIAL INSTRUMENTS

           The carrying amount reported in the balance sheets for cash and cash equivalents, accounts receivable, and accounts payable approximate fair value because of the immediate or short-term maturity of these financial instruments.

RECLASSIFICATIONS

           Certain amounts in 2010 were reclassified to conform to the 2011 presentation. These reclassifications had no effect on net loss for the periods presented.

NOTE 3 - STOCKHOLDERS' EQUITY

           Effective as of June 20, 2011, the Company effectuated a 1-for-10 reverse stock split.  All share and per share data for all prior periods presented have been revised to give retroactive effect to the reverse stock split.

SERIES A PREFERRED STOCK

As of September 30, 2011, the Company had 100,000 shares of Series A Preferred Stock   authorized, $0.001 par value per share, and 5,546 shares were issued and outstanding.   Each holder of the Series A Preferred Stock may convert each share of Preferred Stock into 19 shares (the “Conversion Ratio”) of the Company’s Common Stock at any time. The Conversion Ratio is subject to adjustment in the event of any recapitalization or reorganization.  Until such shares of Series A Preferred Shares are exchanged for the Company’s Common Shares, each holder of a Series A Preferred Share shall be entitled to one vote per share and will vote together with holders of the Company’s Common Stock and Series C Preferred Stock on all matters which are brought to a vote of the holders of our Common Stock at an annual or special meeting (or pursuant to a written consent), except with respect to the election of directors and as otherwise required by Florida law.  Holders of the Series A Preferred Stock have no other rights or preferences. As of September 30, 2011, a total of 47,727 shares of Series A Preferred Stock have been converted into 906,813 shares of our Common Stock. There were no shares of Series A Preferred Stock converted into Common Stock during the three or nine months ended September 30, 2011.

SERIES B PREFERRED STOCK

As of September 30, 2011, the Company has 50,000 shares of Series B Preferred Stock authorized, $0.001 par value per share, and -0- shares issued and outstanding.  Each share of Series B Preferred Stock had 10 votes per share and will vote together with holders of the Company's common stock and Series C Preferred Stock as a single class on all matters presented to the Company's shareholders at an annual or special meeting (or pursuant to written consent), except with respect to the matters relating to the election of directors or as otherwise required by Florida law.  The Series B Preferred Stock does not have any dividend or liquidation preferences and is not convertible into shares of the Company’s Common Stock.

10

SERIES C PREFERRED STOCK

As of September 30, 2011, the Company has 215,000 shares of Series C Preferred Stock authorized, $0.001 par value per share, and 215,000 shares issued and outstanding.  Each share of Series C Preferred Stock has 100 votes per share and will vote together with holders of the Company's common stock and Series A Preferred Stock as a single class on all matters presented to the Company's shareholders at an annual or special meeting (or pursuant to written consent), except with respect to the matters relating to the election of directors or as otherwise required by Florida law.  The holders of a majority of shares of the Company's Series C Preferred Stock will have the right to appoint a majority of the directors serving on the Company's Board. The Series C Preferred Stock does not have any dividend or liquidation preferences and is not convertible into shares of the Company’s Common Stock.

During the period ended June 30, 2011, 50,000 shares of Series B Preferred Stock were relinquished and replaced by 5,000 shares of Series C Preferred Stock. Also, 90,000 shares of Series C Preferred Stock were issued during that period to management for services rendered to the Company. The Company determined that the fair value of the shares of Series C Preferred Stock was insignificant.

COMMON STOCK

As of September 30, 2011, the Company has 20,000,000 shares of common stock authorized, $0.001 par value per share, and 14,129,666 shares issued and outstanding.

During the nine months ended September 30, 2011, the Company sold 2,979,270 shares of its common stock for total net proceeds of $777,530. In addition, during the same period warrants to purchase 160,000 shares of common stock were exercised for total net proceeds of $1,600.  During the three months ended September 30, 2011, the Company sold 2,101,000 shares of its common stock for total net proceeds of $475,250.

In October 2011, the Company sold 1,876,666 shares of its common stock for total net proceeds of $302,500.

NOTE 4 - STOCK OPTIONS AND WARRANTS

At September 30, 2011, the Company had one stock option plan, its 2010 Stock Option Plan ("Plan").  We have reserved an aggregate of one million shares of common stock for issuance under the Plan, which provides for the granting of options, restricted stock, stock appreciation rights, performance shares and performance units to our employees, consultants and non-employee directors.

The Company accounts for the fair value of its grants under this plan in accordance with ASC718. The compensation cost that has been charged to operations for this plan is $0 for the three and nine months ended September 30, 2011 and 2010, respectively.

There were no stock options outstanding and exercisable at September 30, 2011.

Warrant Grants

In connection with various equity financings, we have outstanding warrants to purchase a total of 501,313 shares of our common stock.

No. of Warrants	Grant Date	Exercise Price	Expiration Date
23,285	2009	$10.00	December 2011
254,728	2009	$7.50	December 2011
223,300	2010	$0.10	December 2012

11

NOTE 5 - PROVISION FOR INCOME TAXES

           The Company reported no tax expense or benefit for the three and nine months ended September 30, 2011 and 2010 due to the net operating losses incurred during the periods and a valuation allowance established against 100% of the Company’s deferred tax assets. At September 30, 2011 and December 31, 2010, deferred tax assets consist of the following:

	2011			2010
Deferred tax asset	$	13,004,000		$	10,540,000
Less: valuation allowance		(13,004,000	)		(10,540,000	)
Net deferred tax assets	$	0		$	0

           As of December 31, 2010, the Company had a net operating loss carry-forward of approximately $31,000,000 available to offset future taxable income through 2026. Under Internal Revenue Service (IRS) Section 382, the future utilization of certain components of the loss carry-forward may be limited. The Company established valuation allowances equal to the full amount of the deferred tax assets due to management’s assessment of the uncertainty of the utilization of the operating losses in the future.

The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than–not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company had no uncertain tax positions as of September 30, 2011 and December 31, 2010. The Company is subject to income taxes in the U.S. federal jurisdiction and a number of state jurisdictions, including the state of Florida. The tax regulations within each jurisdiction are subject to interpretation of related tax laws and regulations and require significant judgment to apply. With few exceptions, the Company is no longer subject to U.S. federal, state and local examinations by tax authorities for the years before 2008.

NOTE 6 – CONCENTRATIONS OF CREDIT RISK

Financial instruments which potentially expose the Company to concentrations of credit risk, consist primarily of trade receivables. The Company has attempted to minimize this risk by monitoring customers’ credit and payment activities.

During the three and nine months ended September 30, 2011 and 2010, no single customer accounted for greater than 10% of revenue.

NOTE 7 - GOING CONCERN

           The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, which contemplates continuation of the Company as a going concern. The Company has sustained operating losses, and does not have enough recurring revenue to sustain its operations. These items raise substantial doubt about the Company's ability to continue as a going concern.

            In view of these matters, realization of the assets of the Company is dependent upon the Company's ability to meet its financial requirements and the success of future operations. These condensed consolidated financial statements do not include adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence. The Company's continued existence is dependent upon its ability to generate sufficient cash flows from equity financing and operating revenues. The Company has historically issued equity securities to fund operations although there is no guarantee of the Company’s ability to do so in the future.

12

NOTE 8 - CONTINGENCIES

Legal Proceedings:

On March 23, 2011, the Company was served with a complaint filed by Nightingale Nurses, LLC ("Nightingale") in the Circuit Court of the Fifteenth Judicial Circuit in and for Palm Beach County, Florida (the "Litigation'") that alleged that the Company breached the terms of a mutual confidentiality agreement between the Company and Nightingale, including certain confidentiality and non-solicitation provisions. Nightingale also alleged that the Company hired four former employees of Nightingale in violation of loyalty pledges that the employees signed with Nightingale. The Company denied all material allegations alleged in the Litigation and denied any wrongdoing and liability of any kind. However, in an effort to avoid the expense, inconvenience, distraction and uncertainty of litigation, on May 24, 2011, the Company and Nightingale entered into a settlement agreement ("Settlement Agreement") that settled all claims each party had against the other party in the Litigation and the dismissal of the Litigation with prejudice. Each party paid their own legal fees relating to the Litigation and the Company made a settlement payment in the amount of $101,000. This expense was included as a component of general and administrative expenses for the three month period ended June 30, 2011. Pursuant to the terms of the Settlement Agreement, the Company and Nightingale each granted the other party a full release of all claims that were or could have been brought against the other party in the Litigation. Nightingale also gave full releases to the four former employees of Nightingale who were alleged to have violated their loyalty pledges.

In December 2010, the Company and our President, Anthony Nicolosi, were served with a Cease and Desist Order (the "Order"), with a Notice of Right To Hearing, from the Alabama Securities Commission styled "In the Matter of Medical Connections Holdings, Inc., Anthony Nicolosi," (Adm. Order No. CD-2010-0062). The Order requires the cessation of offering or selling securities into, within or from the State of Alabama during the pendency of the Order. The Cease and Desist Order alleges that Mr. Nicolosi omitted material facts in the sale of a security to a single Alabama investor and violated the agent registration requirements in Alabama. The Company made a rescission offer to the Alabama investor which included information that the Alabama Securities Commission alleged should have been disclosed to the investor relating to the name change of Mr. Nicolosi and his regulatory history concerning a disciplinary proceeding instituted by the Financial Industry Regulatory Authority (FINRA) and settled by means of an Acceptance Waiver and Consent. The Alabama investor rejected the rescission offer. The Company had an informal meeting with the Alabama Securities Commission in March 2011 and is in the process of attempting to resolve the matter. There has been no adjudication as to the truth of the allegations upon which the Order was based.

The Company and certain of its subsidiaries are subject to other various pending or threatened legal proceedings arising out of the normal course of business or operations. In view of the inherent difficulty of predicting the outcome of such matters, the Company cannot state what the eventual outcome of these matters will be. However, based on current knowledge, management believes that current reserves, determined in accordance with ASC 450 (formerly SFAS No. 5, “Accounting for Contingencies”), are adequate, and the amount of any incremental liability arising from these matters is not expected to have a material adverse effect on the Company’s consolidated financial condition or results of operations.

13

ITEM 2.        MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

    In this Quarterly Report on Form 10-Q, the terms "Company," "we," "us," and "our" refer to Medical Connections Holdings, Inc.  and its wholly-owned and majority-owned subsidiaries.

Forward Looking Statements

                This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact, including statements regarding  industry prospects or future results of operations or financial position, made in this Quarterly Report on Form 10-Q are forward-looking. We use words such as anticipates, believes, expects, future, intends, and similar expressions to identify forward-looking statements. Forward-looking statements reflect management’s current expectations and are inherently uncertain. Actual results could differ materially for a variety of reasons, including, those risks described in our Annual Report on Form 10-K/A ("2010 Amended Annual Report") for the year ended December 31, 2010 filed with the Securities and Exchange Commission (“SEC”) on July 1, 2011, and the risks discussed in other SEC filings. These risks and uncertainties, as well as other risks and uncertainties, could cause our actual results to differ significantly from management’s expectations. The forward-looking statements included in this Quarterly Report on Form 10-Q reflect the beliefs of our management on the date of this report. We undertake no obligation to update publicly any forward-looking statements for any reason.

General

We are a healthcare staffing company which provides staffing services for allied professionals and nurses to our clients on a national basis.  We provide recruiting and staffing services for permanent and temporary positions, with an option for the clients and candidates to choose the most beneficial working arrangements.

We operate under a holding company structure and currently have one direct wholly-owned operating subsidiary, Medical Connections, Inc., a Florida corporation ("Medical Connections") which was formed in 2002.

On June 20, 2011, we effectuated a 1-for-10 reverse stock split.  All share and per share data have been revised to give retroactive effect to the reverse stock split.

14

Executive Overview

We generate revenues primarily from travel contract appointments and permanent placement hires:

Contract Appointments: This activity represents temporary hires (typically, 13 week contracts) made by healthcare facilities to cover short term staffing needs at their facilities.  These shortages in staffing may occur for a variety of reasons, including high-seasonal activity at the healthcare facility, or permanent employees may be taking vacations or leaves of absence. This also includes contracts for what is commonly known as “travel positions,” which are for allied health professionals, nurses or physicians who are willing to take temporary assignments outside their home region. Under this arrangement, we are the employer of record for the healthcare professional. The healthcare facility remits a fee to us that includes all employment overhead, as well as a surcharge for the service. The revenue from this activity is earned from the commission and surcharge for the service and is recorded on a gross basis.

Permanent Placement Hires: This activity includes the hiring of allied health professionals, nurses, physicians, pharmacists and other medical personnel to be employed in healthcare or research facilities. Under this arrangement, we receive a placement fee ranging from 10% to 30% of the employee’s initial annual salary, or a negotiated fee, which is predetermined based upon medical specialty.

For the three months ended September 30, 2011, our revenue was  $1,362,871, derived primarily from allied and nursing travel contacts, and our net loss was $942,806 or $(0.07) per share which was a 20.4% improvement when compared to the third quarter of 2010.  Loss from operations was $832,006 for the three months ended September 30, 2011 which was consistent with our operating loss for the third quarter 2010.

Due to the operating losses and deficits, our prior registered public accounting firm raised doubts about our ability to continue as a going concern in their report dated March 30, 2011 on our audited financial statements for our fiscal year ended December 31, 2010.  Despite historical losses, we believe that we will be able to satisfy ongoing operating expenses. We have done so to date by raising capital through the sale of equity securities. We will continue to do so, and/or consider other alternatives for raising capital, including but not limited to the sale of preferred stock or debt securities and/or seek financing from third party lenders, until such time as revenues from operations satisfy operating expenses. There can be no assurance that we will be able to raise capital or third party financing will be available, or if available, will be offered on terms that will not adversely impact our shareholders.

We manage our day-to-day operations by focusing on key metrics such as number of travelers placed with healthcare facilities, permanent placement orders filled with employers, gross margins on each contract, number of hours worked, and profitability of each contract. We also closely monitor our accounts receivable, to make sure we are within contract payment terms. Our sales staff is given specific goals by which their performance is consistently measured.

Our goal is to continue to grow the Company both organically and by acquisition. Organically, we will need to attain new nationwide contracts with healthcare facilities and to locate and place qualified allied and nursing professionals into these facilities. With acquisitions, we will need to locate other allied/nursing staffing companies whose business matches our own in order to successfully integrate operations. Both efforts have challenges associated with them. Organic growth will require us to obtain new contracts and professionals daily and to do so in an economy that remains lackluster. With acquisitions, we will need to locate, purchase, and integrate a similar sized company or companies with a similar business model in order to maximize the accretiveness of the transaction. There can be no assurances that we will be able to implement such plans.

15

Three Months Ended September 30, 2011 (“third quarter of 2011”) Compared with Three Months Ended September 30, 2010 (“third quarter of 2010”)

Revenue for the third quarter of 2011 was $1,362,871, a decrease of $901,842, or 39.8%, when compared with $2,264,713 in the third quarter of 2010.   The two main components of revenue are contract appointments and permanent placement hires.

Revenue from contract appointments was $1,256,048, a decrease of $758,104 or 37.6% when compared with revenue of $2,014,152 in the third quarter 2010.  During the third quarter of 2011, the Company continued to focus on acquiring higher margin contracts and discontinuing split-fee and other low margin placements.  While this effort resulted in a decrease in total revenue in the third quarter, it also resulted in a 62.9% improvement in gross profit margin (21.1% in the third quarter 2011 compared to 12.9% gross profit margin in the third quarter 2010).

Revenue from permanent placement hires decreased $143,738, or 57.4%, to $106,823 for the third quarter of 2011 compared with $250,561 in the third quarter of 2010. The decrease in permanent placement hires in the third quarter of 2011 was due to the uncertain economic conditions at present and the resultant hesitancy of employers to hire full time employees.

Direct costs associated with contract appointments decreased $765,127, or 43.6%, to $990,624 in the third quarter of 2011 compared with $1,755,751 in the third quarter of 2010.  The decrease was the result of higher margin placements and lower revenue during the period. The gross profit from contract appointments increased to $265,424 or 21.1% of revenue in the third quarter of 2011 compared with $261,152 or 12.9% of revenue in the third quarter of 2010.

           Sales and marketing expenses were $60,394 in the third quarter of 2011, an increase of $29,842 or 97.7% when compared to the $30,552 expensed in the third quarter of 2010. The increase is related to the Company’s increased marketing efforts to gain new revenue.

Recruiting salaries and costs decreased $80,469, or 19.1%, to $340,331 in the third quarter of 2011, due to lower commission expense resulting from the decrease in placements.

Professional and consulting fees decreased $11,030 or 15.1%%, to $62,074 in the third quarter of 2011 compared with $73,104 in the third quarter of 2010 due to reductions in the need for  outside services and consultants.

General and administrative expenses (G&A) decreased $78,051, or 9.5%, to $741,454 in the third quarter of 2011 from $819,505 in the third quarter of 2010.  Reductions in G&A were due primarily to lower compensation and rent expenses.

Other expenses, net in the third quarter of 2011 were $110,800, a decrease of $238,836, or 68.3%, when compared with $349,636 in other expenses, net in the third quarter of 2010.  The decrease was primarily related to the decrease in investor relations expenses.

Net losses for the third quarters ended September 30, 2011 and September 30, 2010 were $942,806 and $1,184,636, respectively, a 20.4% improvement when comparing third quarter 2011 to third quarter 2010.

16

Nine Months Ended September 30, 2011 (“first nine months of 2011”) compared to the Nine Months Ended September 30, 2010 (“first nine months of 2010”)

Revenue for the first nine months of 2011 was $5,173,448, a decrease of $430,057, or 7.7%, when compared with $5,603,505 in the first nine months of 2010.   The two main components of revenue are contract appointments and permanent placement hires.

Revenue from contract appointments was $4,740,562, a decrease of $79,811 or 1.7% when compared with $4,820,373 in the first nine months of 2010.   During the first nine months of 2011, the Company discontinued split-fee and other low margin placements.  This resulted in a 54.3% improvement in its gross profit margin (19.6% for the first nine months of 2011 compared with 12.7% for the first nine months of 2010).

Revenue from permanent placement hires decreased $350,244, or 44.7%, to $432,886 in the first nine months of 2011 compared with $783,132 in the first nine months of 2010. The decrease in permanent placement hires was due to the ongoing employer uncertainty regarding the hiring of permanent employees given the economic conditions, especially during the second and third quarter of this year.

Direct costs associated with contract appointments decreased $398,868, or 9.5%, to $3,810,288 in the first nine months of 2011 from $4,209,156 in the first nine months of 2010. The decrease was the result of higher margin placements and lower revenue during the period. The gross profit from contract appointments increased in the first nine months of 2011 to $930,274, or 19.6% of revenue compared to $611,217 or 12.7% of revenue in the first nine months of 2010.  This margin improvement was due to the Company discontinuing low margin split-fee placements and focusing on its own placements primarily during the second and third quarters 2011.

           Sales and marketing expenses were $147,241 in the first nine months of 2011, an increase of $5,455 or 3.8% as compared with $141,786 in the first nine months of 2010. The increase is related to the Company’s increased marketing efforts to gain new revenue.

Recruiting salaries and costs decreased $223,817, or 17.5%, to $1,052,939 in the first nine months of 2011 from $1,276,756 in the first nine months of 2010 due to due to lower commission expense resulting from the decrease in placements.

Professional and consulting fees decreased $207,510, or 50.3%, to $205,371 in the first nine months of 2011 compared with $412,881 in the first nine months of 2010 due to further reductions in the use of outside services and consultants.

 General and administrative expenses (G&A) decreased $367,952, or 13.2%, to $2,415,133 in the first nine months of 2011 from $2,783,085 in the first nine months of 2010.  Reductions in G&A were achieved even with the second quarter of 2011 including expenses of $228,378 relating to a litigation settlement and associated legal expenses. In addition, further reductions in G&A were due primarily to lower compensation and rent expenses.

Other expenses, net in the first nine months 2011 were $287,294, a decrease of $2,212,154, or 88.5%, when compared with $2,499,448 in the first nine months of 2010.  The decrease was primarily related to the decrease in investor relations expenses.

17

Net losses for the first nine months of 2011 and 2010 were $2,745,320 and $5,725,109, respectively. Adjusted for the litigation and related legal expenses totaling $228,378 in the second quarter 2011, the net loss would have been $2,516,942 for the first nine months of 2011, a decrease of $3,208,167 or 56.1% compared with the $5,725,109 net loss in the first nine months of 2010.

Liquidity and Capital Resources

As of September 30, 2011, total current assets were $1,121,291 as compared with $3,053,532 on December 31, 2010. The decrease in total current assets was primarily attributable to the use of cash for operating activities during the first nine months of 2011. Total current liabilities remained relatively static at $408,470 when compared with the $499,626 balance as of December 31, 2010.

 Due to the operating losses and deficits, our prior registered public accounting firm raised doubts about our ability to continue as a going concern in their report dated March 30, 2011 on our audited financial statements for our fiscal year ended December 31, 2010.  Despite historical losses, we believe that we will be able to satisfy ongoing operating expenses. We have done so to date by raising capital through the sale of our equity securities. We will continue to do so, and/or consider other alternatives for raising capital, including but not limited to the sale of preferred stock or debt securities and/or seek financing from third party lenders, until such time as revenues from operations satisfy operating expenses. There can be no assurance that we will be able to raise capital or third party financing will be available, or if available, will be offered on terms that will not adversely impact our stockholders.

For the three month period ended September 30, 2011, we raised $475,250 from the sale of 2,101,000 shares of our common stock in private offerings. For the nine month period ended September 30, 2011, we raised $777,530 from the sale of 2,979,270 shares of our common stock in private offerings. During the month of October 2011, we raised $302,500 from the sale of 1,876,666 shares of our common stock in private offerings.

Net cash used in operating activities was $2,120,651 in the first nine months of 2011 compared with $5,362,180 for the same period in 2010. This change principally results from our decreased net loss from operations and net collection of accounts receivable in 2011.

Net cash flow used in investing activities was $28,994 in the first nine months of 2011 compared with net cash used in investing activities of $530,361 for the same period in 2010. The decrease was due to a significant reduction in the acquisition of property and equipment in the 2011 period.

Net cash provided by financing activities was $777,530 in the first nine months of 2011 compared with $5,334,648 in the first nine months of 2010 which is due to decreased sales of our common stock in the first  nine months of 2011.

Our corporate headquarters are located at 4800 T-Rex Avenue, Suite 310, Boca Raton, Florida 33431. We operate Medical Connections, Inc. from this office. We lease approximately 10,000 square feet of space with a monthly base rent expense of $14,245. Additionally, reimbursement of lessor operating expenses and taxes are approximately $7,400 per month. Our current lease expires on May 15, 2016.

Critical Accounting Policies

The discussion and analysis of our financial condition and results of operations are based upon our Condensed Consolidated Financial Statements, which have been prepared in conformity with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. Actual results could differ from these estimates under different assumptions or conditions. The impact and any associated risks related to these policies on our business operations is discussed throughout “Management’s Discussion and Analysis of Financial Condition and Results of Operations” where such policies affect reported and expected financial results. For a detailed discussion on the application of these and other accounting policies, see Note 2 — Significant Accounting Policies and Related Information, in the Notes to Consolidated Financial Statements, along with the discussion of Critical Accounting Policies, included in our 2010 Amended Annual Report filed with the SEC on July 1, 2011. There have been no significant changes to our critical accounting policies since December 31, 2010.

18

Off-Balance Sheet Arrangements

We have not entered into any off-balance sheet arrangements. We do not anticipate entering into any off-balance sheet arrangements during the next 12 months.

ITEM 3.        QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4.        CONTROLS AND PROCEDURES
 

(a)           Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) and determined that our disclosure controls and procedures were effective as of September 30, 2011. The evaluation considered the procedures designed to ensure that the information required to be disclosed by us in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

(b)           Changes in Internal Control over Financial Reporting

During the period covered by this Quarterly Report on Form 10-Q, there was no change in our internal control over financial reporting (as such term is defined in Rules 13a-15(d) and 13d-15(d) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

(c)            Inherent Limitations of Disclosure Controls and Internal Controls over Financial Reporting

Because of its inherent limitations, internal controls over financial reporting may not prevent or detect misstatements. Projections of any evaluation or effectiveness to future periods are subject to risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

19

PART II. OTHER INFORMATION

ITEM 1.        LEGAL PROCEEDINGS.

See Note 8 — Contingencies in the Notes to Condensed Consolidated Financial Statements contained in PART I, ITEM I of this Quarterly Report for information about legal proceedings in which we are involved.

ITEM 1A.     RISK FACTORS.

There have been no material changes in the risk factors associated with the Company’s operations since the filing of the Company’s 2010 Amended Annual Report, which was filed with the SEC on July 1, 2011.

ITEM 2.        UNREGISTERED SALES OF EQUITY SECURITIES

During the three month period ended September 30, 2011, we sold 2,101,000 shares of our common stock to accredited or sophisticated investors for aggregate gross proceeds of $475,250. These securities were issued in transactions that were exempt from registration under Regulation D Rule 506 and/or Section 4(2) of the Securities Act of 1933, as amended (“Securities Act”), as transactions by an issuer not involving a public offering.   All of the investors were knowledgeable, sophisticated and had access to comprehensive information about the Company and represented their intention to acquire the securities for investment only and not with a view to distribute or sell the securities. The Company placed legends on the securities stating that the securities were not registered under the Securities Act and set forth the restrictions on their transferability and sale.

ITEM 3.        DEFAULTS UPON SENIOR SECURITIES

None

ITEM 4.        (REMOVED AND RESERVED)

Not Applicable.

ITEM 5.        OTHER INFORMATION

None

20

ITEM 6.        EXHIBITS

Exhibit No.	Exhibit Description
31.1	Certification by the Chief Executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.+
31.2	Certification by the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. +
32.1	Certification by Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. +
32.2	Certification by Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. +

_____

+ Filed herewith

21

SIGNATURES

            Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized

	MEDICAL CONNECTIONS HOLDINGS, INC.
Date:  November 14, 2011	By:	/s/ Jeffrey Rosenfeld
		Jeffrey Rosenfeld,
		Chief Executive Officer and Director

         In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Date:  November 14, 2011	By:	/s/ Jeffrey Rosenfeld
		Jeffrey Rosenfeld,
		Chief Executive Officer and Director
		(Principal Executive Officer)

Date:  November 14, 2011	By:	/s/ Brian Neill
		Brian Neill,
		Chief Financial Officer
		(Principal Financial/Accounting Officer)

22

EX-31.1

EXHIBIT 31.1

CERTIFICATIONS

I, Jeffrey Rosenfeld, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended September 30, 2011 of Medical Connections Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  November 14, 2011	By:	/s/ Jeffrey Rosenfeld
		Jeffrey Rosenfeld,
		Chief Executive Officer and Director

EX-31.2

EXHIBIT 31.2

CERTIFICATIONS

I, Brian Neill, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended September 30, 2011 of Medical Connections Holdings, Inc.:

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  November 14, 2011	By:	/s/ Brian Neill
		Brian Neill,
		Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Medical Connections Holdings, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2011 as filed with the Securities and Exchange Commission (the "Report"), I, Jeffrey Rosenfeld, Chief Executive Officer, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

Date: November 14, 2011	By:	/s/ Jeffrey Rosenfeld
		Jeffrey Rosenfeld,
		Chief Executive Officer

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Medical Connections Holdings, Inc. (the "Company") on Form 10-Q for the quarter ended September 30, 2011 as filed with the Securities and Exchange Commission (the "Report"), I, Brian Neill, Chief Financial Officer of the Company, , hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

Date: November 14, 2011	By:	/s/ Brian Neill
		Brian Neill,
		Chief Financial Officer

XML

Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2011	Dec. 31, 2010
ASSETS
Intangible asset, net of amortization	$ 210,000	$ 142,500
Stockholders' equity
Preferred stock, Class A, par value	$ 0.001	$ 0.001
Preferred stock, Class A, authorized shares	100,000	100,000
Preferred stock, Class A, issued shares	5,546	5,546
Preferred stock, Class A, outstanding shares	5,546	5,546
Preferred stock, Class B, par value	$ 0.001	$ 0.001
Preferred stock, Class B, authorized shares	50,000	50,000
Preferred stock, Class B, issued shares	0	50,000
Preferred stock, Class B, outstanding shares	0	50,000
Preferred stock, Class C, par value	$ 0.001	$ 0.001
Preferred stock, Class C, authorized shares	215,000	215,000
Preferred stock, Class C, issued shares	215,000	120,000
Preferred stock, Class C, outstanding shares	215,000	120,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, authorized shares	20,000,000	20,000,000
Common stock, issued shares	14,129,666	11,150,396
Common stock, outstanding shares	14,129,666	11,150,396

XML

Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Income Statement [Abstract]
Revenue	$ 1,362,871	$ 2,264,713	$ 5,173,448	$ 5,603,505
Direct costs of revenue	990,624	1,755,751	3,810,790	4,214,657
Advertising and marketing expenses	60,394	30,552	147,241	141,786
Recruiting - salaries and costs	340,331	420,800	1,052,939	1,276,756
Professional and consulting fees	62,074	73,104	205,371	412,881
General and administration expenses	741,454	819,505	2,415,133	2,783,085
Total operating expenses	2,194,877	3,099,712	7,631,474	8,829,165
Loss from operations	(832,006)	(834,999)	(2,458,026)	(3,225,660)
Other expenses, net	110,800	349,636	287,294	2,499,448
Loss before income taxes	(942,806)	(1,184,635)	(2,745,320)	(5,725,108)
Income taxes	0	0	0	0
Net (loss)	$ (942,806)	$ (1,184,635)	$ (2,745,320)	$ (5,725,109)
Net loss per common share - basic and fully diluted	$ (0.07)	$ (0.16)	$ (0.23)	$ (0.86)
Weighted average common shares outstanding- basic and fully diluted	13,097,401	7,523,182	11,914,010	6,666,178

XML

Document and Entity Information (USD $)	9 Months Ended
	Sep. 30, 2011	Oct. 31, 2011
Document And Entity Information
Entity Registrant Name	MEDICAL CONNECTIONS HOLDINGS, INC.
Entity Central Index Key	0001140303
Document Type	10-Q
Document Period End Date	Sep. 30, 2011
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float		$ 15,777,498
Entity Common Stock, Shares Outstanding		15,994,333
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2011

XML

Going Concern

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements

Going Concern

NOTE 7 - GOING CONCERN

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, which contemplates continuation of the Company as a going concern. The Company has sustained operating losses, and does not have enough recurring revenue to sustain its operations. These items raise substantial doubt about the Company's ability to continue as a going concern.

In view of these matters, realization of the assets of the Company is dependent upon the Company's ability to meet its financial requirements and the success of future operations. These condensed consolidated financial statements do not include adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence. The Company's continued existence is dependent upon its ability to generate sufficient cash flows from equity financing and operating revenues. The Company has historically issued equity securities to fund operations although there is no guarantee of the Company’s ability to do so in the future.

XML

Stockholders Equity

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements

Stockholders Equity

NOTE 3 - STOCKHOLDERS' EQUITY

Effective as of June 20, 2011, the Company effectuated a 1-for-10 reverse stock split. All share and per share data for all prior periods presented have been revised to give retroactive effect to the reverse stock split.

SERIES A PREFERRED STOCK

As of September 30, 2011, the Company had 100,000 shares of Series A Preferred Stock authorized, $0.001 par value per share, and 5,546shareswere issued and outstanding. Each holder of the Series A Preferred Stock may convert each share of Preferred Stock into 19 shares (the “Conversion Ratio”) of the Company’s Common Stock at any time. The Conversion Ratio is subject to adjustment in the event of any recapitalization or reorganization. Until such shares of Series A Preferred Shares are exchanged for the Company’s Common Shares, each holder of a Series A Preferred Share shall be entitled to one vote per share and will vote together with holders of the Company’s Common Stock and Series C Preferred Stock on all matters which are brought to a vote of the holders of our Common Stock at an annual or special meeting (or pursuant to a written consent), except with respect to the election of directors and as otherwise required by Florida law. Holders of the Series A Preferred Stock have no other rights or preferences. As of September 30, 2011, a total of 47,727 shares of Series A Preferred Stock have been converted into 906,813 shares of our Common Stock. There were no shares of Series A Preferred Stock converted into Common Stock during the three or nine months ended September 30, 2011.

SERIES B PREFERRED STOCK

As of September 30, 2011, the Company has 50,000 shares of Series B Preferred Stock authorized, $0.001 par value per share, and -0- shares issued and outstanding. Each share of Series B Preferred Stock had 10 votes per share and will vote together with holders of the Company's common stock and Series C Preferred Stock as a single class on all matters presented to the Company's shareholders at an annual or special meeting (or pursuant to written consent), except with respect to the matters relating to the election of directors or as otherwise required by Florida law. The Series B Preferred Stock does not have any dividend or liquidation preferences and is not convertible into shares of the Company’s Common Stock.

SERIES C PREFERRED STOCK

As of September 30, 2011, the Company has 215,000 shares of Series C Preferred Stock authorized, $0.001 par value per share, and 215,000 shares issued and outstanding. Each share of Series C Preferred Stock has 100 votes per share and will vote together with holders of the Company's common stock and Series A Preferred Stock as a single class on all matters presented to the Company's shareholders at an annual or special meeting (or pursuant to written consent), except with respect to the matters relating to the election of directors or as otherwise required by Florida law.  The holders of a majority of shares of the Company's Series C Preferred Stock will have the right to appoint a majority of the directors serving on the Company's Board. The Series C Preferred Stock does not have any dividend or liquidation preferences and is not convertible into shares of the Company’s Common Stock.

During the period ended June 30, 2011, 50,000 shares of Series B Preferred Stock were relinquished and replaced by 5,000 shares of Series C Preferred Stock. Also, 90,000 shares of Series C Preferred Stock were issued during that period to management for services rendered to the Company. The Company determined that the fair value of the shares of Series C Preferred Stock was insignificant.

COMMON STOCK

As of September 30, 2011, the Company has 20,000,000 shares of common stock authorized, $0.001 par value per share, and 14,129,666 shares issued and outstanding.

During the nine months ended September 30, 2011, the Company sold 2,979,270 shares of its common stock for total net proceeds of $777,530. In addition, during the same period warrants to purchase 160,000 shares of common stock were exercised for total net proceeds of $1,600. During the three months ended September 30, 2011, the Company sold 2,101,000 shares of its common stock for total net proceeds of $475,250.

In October 2011, the Company sold 1,876,666 shares of its common stock for total net proceeds of $302,500.

XML

Contingencies

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements

Contingencies

NOTE 8 - CONTINGENCIES

Legal Proceedings:

On March 23, 2011, the Company was served with a complaint filed by Nightingale Nurses, LLC ("Nightingale") in the Circuit Court of the Fifteenth Judicial Circuit in and for Palm Beach County, Florida (the "Litigation'") that alleged that the Company breached the terms of a mutual confidentiality agreement between the Company and Nightingale, including certain confidentiality and non-solicitation provisions. Nightingale also alleged that the Company hired four former employees of Nightingale in violation of loyalty pledges that the employees signed with Nightingale. The Company denied all material allegations alleged in the Litigation and denied any wrongdoing and liability of any kind. However, in an effort to avoid the expense, inconvenience, distraction and uncertainty of litigation, on May 24, 2011, the Company and Nightingale entered into a settlement agreement ("Settlement Agreement") that settled all claims each party had against the other party in the Litigation and the dismissal of the Litigation with prejudice. Each party paid their own legal fees relating to the Litigation and the Company made a settlement payment in the amount of $101,000. This expense was included as a component of general and administrative expenses for the three month period ended June 30, 2011. Pursuant to the terms of the Settlement Agreement, the Company and Nightingale each granted the other party a full release of all claims that were or could have been brought against the other party in the Litigation. Nightingale also gave full releases to the four former employees of Nightingale who were alleged to have violated their loyalty pledges.

In December 2010, the Company and our President, Anthony Nicolosi, were served with a Cease and Desist Order (the "Order"), with a Notice of Right To Hearing, from the Alabama Securities Commission styled "In the Matter of Medical Connections Holdings, Inc., Anthony Nicolosi," (Adm. Order No. CD-2010-0062). The Order requires the cessation of offering or selling securities into, within or from the State of Alabama during the pendency of the Order. The Cease and Desist Order alleges that Mr. Nicolosi omitted material facts in the sale of a security to a single Alabama investor and violated the agent registration requirements in Alabama. The Company made a rescission offer to the Alabama investor which included information that the Alabama Securities Commission alleged should have been disclosed to the investor relating to the name change of Mr. Nicolosi and his regulatory history concerning a disciplinary proceeding instituted by the Financial Industry Regulatory Authority (FINRA) and settled by means of an Acceptance Waiver and Consent. The Alabama investor rejected the rescission offer. The Company had an informal meeting with the Alabama Securities Commission in March 2011 and is in the process of attempting to resolve the matter. There has been no adjudication as to the truth of the allegations upon which the Order was based.

 The Company and certain of its subsidiaries are subject to other various pending or threatened legal proceedings arising out of the normal course of business or operations. In view of the inherent difficulty of predicting the outcome of such matters, the Company cannot state what the eventual outcome of these matters will be. However, based on current knowledge, management believes that current reserves, determined in accordance with ASC 450 (formerly SFAS No. 5, “Accounting for Contingencies”), are adequate, and the amount of any incremental liability arising from these matters is not expected to have a material adverse effect on the Company’s consolidated financial condition or results of operations.

XML

Organization And Basis Of Presentation

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements

Organization And Basis Of Presentation

NOTE 1 - ORGANIZATION AND BASIS OF PRESENTATION

Medical Connections Holdings, Inc. and its wholly-owned subsidiary (the "Company," "we" or "us") is a healthcare staffing company which provides staffing services for allied professionals and nurses to our clients on a national basis. We provide recruiting and staffing services for permanent and temporary positions, with an option for the clients and candidates to choose the most beneficial working arrangements.

The Company operates under a holding company structure and has one direct wholly-owned operating subsidiary, Medical Connections, Inc., a Florida corporation ("Medical Connections") which was formed in 2002.

On June 20, 2011, the Company effectuated a 1-for-10 reverse stock split. All share and per share data for all periods presented have been revised to give retroactive effect to the reverse stock split.

In our opinion, the accompanying condensed consolidated balance sheets and related condensed consolidated interim statements of operations and cash flows include the adjustments (consisting of normal and recurring items) necessary for their fair presentation in conformity with United States generally accepted accounting principles ("GAAP") and represent our accounts after the elimination of inter-company transactions. The unaudited information included in this Form 10-Q should be read in conjunction with the consolidated financial statements contained in our 2010 Annual Report on Form 10-K/A which was filed with the Securities and Exchange Commission on July 1, 2011. Interim results are not necessarily indicative of expected results for a full year or for any interim periods in the future.

XML

Stock Options And Warrants

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements

Stock Options And Warrants

NOTE 4 - STOCK OPTIONS AND WARRANTS

At September 30, 2011, the Company had one stock option plan, its 2010 Stock Option Plan ("Plan").  We have reserved an aggregate of one million shares of common stock for issuance under the Plan, which provides for the granting of options, restricted stock, stock appreciation rights, performance shares and performance units to our employees, consultants and non-employee directors.

The Company accounts for the fair value of its grants under this plan in accordance with ASC718. The compensation cost that has been charged to operations for this plan is $0 for the three and nine months ended September 30, 2011 and 2010, respectively.

There were no stock options outstanding and exercisable at September 30, 2011.

Warrant Grants

In connection with various equity financings, we have outstanding warrants to purchase a total of 501,313 shares of our common stock.

No. of Warrants	Grant Date		Exercise Price		Expiration Date
23,285		2009	$	10.00		Dec-11
254,728		2009	$	7.50		Dec-11
223,300		2010	$	0.10		Dec-12

XML

Provision For Income Taxes

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements

Provision For Income Taxes

NOTE 5 - PROVISION FOR INCOME TAXES

The Company reported no tax expense or benefit for the three and nine months ended September 30, 2011 and 2010 due to the net operating losses incurred during the periods and a valuation allowance established against 100% of the Company’s deferred tax assets. At September 30, 2011 and December 31, 2010, deferred tax assets consist of the following:

	2011			2010
Deferred tax asset	$	13,004,000		$	10,540,000
Less: valuation allowance		(13,004,000	)		(10,540,000	)
Net deferred tax assets	$	0		$	0

As of December 31, 2010, the Company had a net operating loss carry-forward of approximately $31,000,000 available to offset future taxable income through 2026. Under Internal Revenue Service (IRS) Section 382, the future utilization of certain components of the loss carry-forward may be limited. The Company established valuation allowances equal to the full amount of the deferred tax assets due to management’s assessment of the uncertainty of the utilization of the operating losses in the future.

The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than–not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company had no uncertain tax positions as of September 30, 2011 and December 31, 2010. The Company is subject to income taxes in the U.S. federal jurisdiction and a number of state jurisdictions, including the state of Florida. The tax regulations within each jurisdiction are subject to interpretation of related tax laws and regulations and require significant judgment to apply. With few exceptions, the Company is no longer subject to U.S. federal, state and local examinations by tax authorities for the years before 2008.

XML

Concentrations Of Credit Risk

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements

Concentrations Of Credit Risk

NOTE 6 – CONCENTRATIONS OF CREDIT RISK

Financial instruments which potentially expose the Company to concentrations of credit risk, consist primarily of trade receivables. The Company has attempted to minimize this risk by monitoring customers’ credit and payment activities.

During the three and nine months ended September 30, 2011 and 2010, no single customer accounted for greater than 10% of revenue.

XML

Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flow from operating activities
Net loss	$ (2,745,320)	$ (5,725,109)
Adjustments to reconcile net loss to net cash
Depreciation and amortization	155,699	108,894
Common stock issued for compensation	0	275,000
CHANGES IN ASSETS AND LIABILITIES
Accounts receivable	561,125	(554,669)
Prepaid expenses	(999)	94,520
Accounts payable and accrued expenses	(91,156)	439,184
Net cash used in operating activities	(2,120,651)	(5,362,180)
Cash flow from investing activities
Acquisition of property and equipment	(28,994)	(530,361)
Net cash used in investing activities	(28,994)	(530,361)
Cash flow from financing activities
Proceeds from issuance of common stock and warrant exercise	777,530	5,334,648
Net cash provided by financing activities	777,530	5,334,648
Net decrease in cash and cash equivalents	(1,372,115)	(557,893)
Cash and cash equivalents at beginning of period	1,698,030	1,017,843
Cash and cash equivalents at end of period	325,915	459,949
Supplemental disclosure of cash flow information:
Interest paid	0	0
Taxes paid	$ 0	$ 0

XML

Summary Of Significant Accounting Policies

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements

Summary Of Significant Accounting Policies

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

PRINCIPLES OF CONSOLIDATION

The consolidated financial statements include the accounts of Medical Connections Holdings, Inc., and its wholly-owned subsidiary. All material inter-company transactions and balances have been eliminated in consolidation.

USE OF ESTIMATES

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

ALLOWANCES FOR DOUBTFUL ACCOUNTS / SALES ALLOWANCE

Accounts are written off when management determines that an account is uncollectible. Recoveries of accounts previously written off are recorded when received. Estimated allowances for doubtful accounts ($50,000 as of September 30, 2011 and December 31, 2010) are determined to reduce the Company's receivables to their carrying value, which approximates fair value. Estimated allowances for sales “falloffs” ($60,000 as of September 30, 2011 and December 31, 2010) provide for that portion of permanent placement revenue that may be discounted after a reasonable period of time. All allowances are estimated based on historical collection experience, specific review of individual customer accounts, and current economic and business conditions. A roll forward of the allowance for doubtful accounts and sales allowances is as follows:

Balance, January 1, 2011	$	110,000
Additions:
Bad debt expense		9,273
Sales allowance		40,654
Deductions:
Write offs		49,927
Balance, September 30, 2011	$	110,000

ADVERTISING

The Company's policy is to expense the costs of advertising and marketing as they are incurred. Advertising expense for the three months ended September 30, 2011 and 2010 was $60,394 and $30,552, respectively. For the first nine months ended September 30, 2011 and 2010, advertising expense was $147,241 and $141,786, respectively.

INCOME TAXES

We account for income taxes in accordance with ASC 740, “Accounting for Income Taxes”, as clarified by ASC 740-10, “Accounting for Uncertainty in Income Taxes”.  Under this method, deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax basis of assets and liabilities given the provisions of enacted tax laws. Deferred income tax provisions and benefits are based on changes to the assets or liabilities from year to year. In providing for deferred taxes, we consider tax regulations of the jurisdictions in which we operate, estimates of future taxable income, and available tax planning strategies. If tax regulations, operating results or the ability to implement tax-planning strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the “more likely than not” criteria of ASC 740.

ASC 740-10 requires that we recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the “more-likely-than-not” threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.

COMMON STOCK ISSUED FOR OTHER THAN CASH

Services purchased and other transactions settled in the Company's common stock are recorded at the estimated fair value of the stock issued if that value is more readily determinable than the fair value of the consideration received.

EARNINGS (LOSS) PER SHARE OF COMMON STOCK

Basic loss per share excludes dilution and is computed by dividing the loss attributable to common shareholders by the weighted-average number of common shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that shared in the loss of the Company. Diluted loss per share is computed by dividing the loss available to common stockholders by the weighted average number of common shares outstanding for the period and dilutive potential common shares outstanding unless consideration of such dilutive potential common shares would result in anti-dilution. Common stock equivalents were not considered in the calculation of diluted loss per share as their effect would have been anti-dilutive for the periods ended September 30, 2011 and 2010. As of September 30, 2011 and 2010, there were common stock equivalents of 606,687 shares excluded from the diluted loss per share calculation.

REVENUE RECOGNITION

The Company records its transactions under the accrual method of accounting whereby revenue is recognized when the services are rendered and collection is reasonably assured. The Company recognizes revenue from permanent placement services when it sends an invoice to the contracting employer, which is typically when the candidate has commenced employment. Adjustments to the fee for these services occur if the candidate’s performance is not satisfactory or if the candidate does not commence work requiring the Company to find a replacement candidate. Contract appointments include contracts for what is commonly known as “travel positions,” which are for allied health professionals, nurses or physicians who are willing to take temporary assignments outside their home region. Under this arrangement, we are the employer of record for the healthcare professional. The healthcare facility remits a fee to us that includes all employment overhead, as well as a surcharge for the service. The revenue from this activity is earned from the commission and surcharge for the service which is billed and recognized as services are rendered.

FAIR VALUE OF FINANCIAL INSTRUMENTS

The carrying amount reported in the balance sheets for cash and cash equivalents, accounts receivable, and accounts payable approximate fair value because of the immediate or short-term maturity of these financial instruments.

RECLASSIFICATIONS

Certain amounts in 2010 were reclassified to conform to the 2011 presentation. These reclassifications had no effect on net loss for the periods presented.

XML

Balance Sheets (Unaudited) (USD $)	Sep. 30, 2011	Dec. 31, 2010
CURRENT ASSETS
Cash	$ 325,915	$ 1,698,030
Accounts receivable, net	791,381	1,352,506
Prepaid expenses	3,995	2,996
Total current assets	1,121,291	3,053,532
Property and equipment	827,228	919,763
Less: accumulated depreciation	280,442	313,772
Total	546,786	605,991
Other assets
Security deposit	200,000	200,000
Intangible asset, net of amortization of $210,000 and $142,500, respectively	61,481	128,981
Total	261,481	328,981
Total assets	1,929,558	3,988,504
Current liabilities
Accounts payable	307,079	324,824
Accrued expenses	101,391	174,802
Total current liabilities	408,470	499,626
Total liabilities	408,470	499,626
Stockholders' equity
Preferred stock, Class A, $.001 par value; 100,000 shares authorized, 5,546 issued and outstanding	5	5
Preferred stock, Class B, $.001 par value; 50,000 shares authorized, -0- and 50,000 issued and outstanding, respectively	0	50
Preferred stock, Class C, $.001 par value; 215,000 shares authorized, 215,000 and 120,000 issued and outstanding, respectively	215	120
Common stock, $.001 par value, 20,000,000 shares authorized,14,129,666 and 11,150,396 issued and outstanding, respectively	14,130	11,150
Additional paid-in capital	45,580,118	44,805,613
Accumulated deficit	(44,073,380)	(41,328,060)
Total stockholders' equity	1,521,088	3,488,878
Total liabilities and stockholders' equity	$ 1,929,558	$ 3,988,504